Sandler Alan B. — SEC insider filings

SEC reporting owner CIK 1835966. 18 insider filings on record with FilingPulse; latest filed 2026-10-01.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2021-04-05 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Revolution Medicines, Inc. (RVMD)Chief Development Officer2—7 legs · 6,650 sh · $1,343,2352
Mirati Therapeutics, Inc. (MRTX)Chief Medical Officer4——8
Zai Lab Ltd (ZLAB)Head of Global Dev., Oncology4——8
Elevation Oncology, Inc. (ELEV)Director4——6
ALX ONCOLOGY HOLDINGS INC (ALXO)Director4——4

Insider filings — Sandler Alan B.

FiledFormIssuerReported transactionsSource
2026-10-014Revolution Medicines, Inc. (RVMD)Option exercise (M): 6,000 @ $58.84 · Sale (S): 2,200 @ $200.82 · Sale (S): 1,609 @ $201.72 · Sale (S): 1,000 @ $202.81 · Sale (S): 1,199 @ $203.91 · Sale (S): 301 @ $204.72 · +1 moreEDGAR
2026-09-184Revolution Medicines, Inc. (RVMD)Sale (S): 5 @ $194.96 · Sale (S): 336 @ $199.30EDGAR
2026-01-214ALX ONCOLOGY HOLDINGS INC (ALXO)Grant/award (A): 10,100 (derivative) @ $0EDGAR
2025-07-244Elevation Oncology, Inc. (ELEV)Disposition to issuer (D): 55,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0EDGAR
2025-06-094Elevation Oncology, Inc. (ELEV)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2025-04-154ALX ONCOLOGY HOLDINGS INC (ALXO)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2024-11-194ALX ONCOLOGY HOLDINGS INC (ALXO)Grant/award (A): 600,000 (derivative) @ $0EDGAR
2024-08-074ALX ONCOLOGY HOLDINGS INC (ALXO)Grant/award (A): 40,400 (derivative) @ $0EDGAR
2024-06-174Elevation Oncology, Inc. (ELEV)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-03-044Elevation Oncology, Inc. (ELEV)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2024-01-234Mirati Therapeutics, Inc. (MRTX)Disposition to issuer (D): 10,547 · Disposition to issuer (D): 52,297 · Disposition to issuer (D): 17,021 · Disposition to issuer (D): 65,000 (derivative)EDGAR
2024-01-034Mirati Therapeutics, Inc. (MRTX)Grant/award (A): 17,021 @ $58.75EDGAR
2023-08-104Mirati Therapeutics, Inc. (MRTX)Grant/award (A): 22,297 @ $37EDGAR
2022-11-084Mirati Therapeutics, Inc. (MRTX)Grant/award (A): 40,000 @ $0 · Grant/award (A): 65,000 (derivative) @ $0EDGAR
2022-06-274Zai Lab Ltd (ZLAB)Grant/award (A): 73,000 (derivative) @ $0EDGAR
2022-04-054Zai Lab Ltd (ZLAB)Option exercise (M): 1,060 @ $0 · Grant/award (A): 87,699 (derivative) @ $0 · Grant/award (A): 16,692 (derivative) @ $0 · Option exercise (M): 1,060 (derivative) @ $0EDGAR
2021-12-034Zai Lab Ltd (ZLAB)Tax withholding (F): 2,075 @ $71.23EDGAR
2021-04-054Zai Lab Ltd (ZLAB)Grant/award (A): 28,000 (derivative) @ $0 · Grant/award (A): 5,300 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-01 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1835966 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs